Comparing the two main trials on HFrEF, it is notable that patients in the EMPEROR-Reduced trial were sicker than those in the DAPA-HF trial judging from their higher levels of NT-proBNP and much more reduced LVEF. The gene discussed is NPPB; the disease is hydrops fetalis.